Management of Methotrexate Toxicity in Patients with Renal Impairment

Immediate Actions and Leucovorin Rescue

The American College of Physicians recommends discontinuing methotrexate immediately upon detection of any signs of toxicity, and initiating leucovorin rescue as soon as possible, with a dose of 10-15 mg orally, intramuscularly, or intravenously every 6 hours until methotrexate levels fall below 0.05 micromolar 1, 2
The British Journal of Dermatology suggests that leucovorin effectiveness decreases dramatically after 24 hours from the last methotrexate dose, emphasizing the need for prompt initiation of rescue therapy 1

In cases of severe toxicity or significant renal impairment, the guideline recommends escalating leucovorin to 100 mg/m² IV every 3 hours, and continuing this higher dose until methotrexate level falls below 1 micromolar, then reducing to 15 mg IV every 3 hours until methotrexate level is below 0.05 micromolar 1
The guideline also suggests monitoring complete blood count, liver function tests, and renal function frequently (every 24 hours initially) until recovery, and considering granulocyte colony-stimulating factor (G-CSF) for severe neutropenia (WBC <2,000 cells/mm³) 1

Patients with creatinine clearance 20-50 mL/min should have their methotrexate dose reduced by 50% at baseline, according to the British Journal of Dermatology 2, 3, 4
Enhanced monitoring (CBC, LFTs, renal function every 2-4 weeks) is essential after any dose adjustment in renal impairment, as recommended by the guideline 3

The guideline warns against using medications that compete for renal tubular secretion, such as NSAIDs, trimethoprim-sulfamethoxazole, penicillins, and proton pump inhibitors, as they can significantly increase methotrexate toxicity risk 1, 3
Folic acid supplementation 1-5 mg daily (except on methotrexate day) can reduce hematologic toxicity risk, according to the British Journal of Dermatology and the guideline 2, 4, 5
Calculating actual creatinine clearance using the Cockcroft-Gault equation, rather than relying on estimated GFR alone, is recommended to prevent toxicity 3